APA
Kim T., Hong J., Oem J., Lee K., Lee H., Kim Y. J., Ryoo S., Ko Y., Park J., Choi J., Lee S. H., Jo H. J., Lee M., Kim B. & Kim J. (20200629). Cross-protective efficacy of the O1 Manisa + O 3039 bivalent vaccine and the O 3039 monovalent vaccine against heterologous challenge with FMDV O/Jincheon/SKR/2014 in pig. : Vaccine.
Chicago
Kim Taeseong, Hong Jang-Kwan, Oem Jae-Ku, Lee Kwang-Nyeong, Lee Hyang-Sim, Kim Yong Joo, Ryoo Soyoon, Ko Young-Joon, Park Jong-Hyeon, Choi Jida, Lee Seung Heon, Jo Hye Jun, Lee Myoung-Heon, Kim Byounghan and Kim Jaejo. 20200629. Cross-protective efficacy of the O1 Manisa + O 3039 bivalent vaccine and the O 3039 monovalent vaccine against heterologous challenge with FMDV O/Jincheon/SKR/2014 in pig. : Vaccine.
Harvard
Kim T., Hong J., Oem J., Lee K., Lee H., Kim Y. J., Ryoo S., Ko Y., Park J., Choi J., Lee S. H., Jo H. J., Lee M., Kim B. and Kim J. (20200629). Cross-protective efficacy of the O1 Manisa + O 3039 bivalent vaccine and the O 3039 monovalent vaccine against heterologous challenge with FMDV O/Jincheon/SKR/2014 in pig. : Vaccine.
MLA
Kim Taeseong, Hong Jang-Kwan, Oem Jae-Ku, Lee Kwang-Nyeong, Lee Hyang-Sim, Kim Yong Joo, Ryoo Soyoon, Ko Young-Joon, Park Jong-Hyeon, Choi Jida, Lee Seung Heon, Jo Hye Jun, Lee Myoung-Heon, Kim Byounghan and Kim Jaejo. Cross-protective efficacy of the O1 Manisa + O 3039 bivalent vaccine and the O 3039 monovalent vaccine against heterologous challenge with FMDV O/Jincheon/SKR/2014 in pig. : Vaccine. 20200629.